0.348
1.43%
0.0049
After Hours:
.34
-0.008
-2.30%
Transcode Therapeutics Inc Stock (RNAZ) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Period Length | 3 Months | 3 Months | 3 Months | 3 Months | 3 Months |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.97%
3.289
|
4.059 | 5.3275 | 5.1308 | 4.9011 |
Interest Income/Expense |
0.00971
|
- | - | - | - |
Operating Income/Loss |
18.97%
-3.289
|
-4.059 | -5.3275 | -5.1308 | -4.9011 |
Nonoperating Income/Loss |
32.68%
-0.0378
|
-0.0285 | 0.0276 | 0.7892 | 0.0842 |
Income/Loss From Continuing Operations Before Tax |
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
Net Income/Loss
|
18.61%
-3.3268
|
-4.0875 | -5.30 | -4.3417 | -4.8169 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
436.13%
5.1424
|
-1.5299 | 3.1572 | 1.3195 | 14.40 |
Diluted Average Shares |
436.13%
5.1424
|
-1.5299 | 3.1572 | 1.3195 | 14.40 |
Basic Earnings Per Share |
99.32%
-0.65
|
-95.15 | -1.68 | -3.29 | -0.33 |
Diluted Earnings Per Share |
99.32%
-0.65
|
-95.15 | -1.68 | -3.29 | -0.33 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):